| Inhibition of KDM2/7 Promotes Notochordal Differentiation of hiPSCs. | Inhibition of KDM2/7 Promotes Notochordal Differentiation of hiPSCs.
Diaz-Hernandez ME, Murakami K, Murata S, Khan NM, Shenoy SPV, Henke K, Yamada H, Drissi H., Free PMC Article | 11/7/2024 |
| The nuclear bodies formed by histone demethylase KDM7A. | The nuclear bodies formed by histone demethylase KDM7A.
Ming H, Wang Q, Zhang Y, Ji L, Cheng L, Huo X, Yan Z, Liu Z, Dang Y, Wen B., Free PMC Article | 09/4/2021 |
| Hsa_circ_002178 Promotes the Growth and Migration of Breast Cancer Cells and Maintains Cancer Stem-like Cell Properties Through Regulating miR-1258/KDM7A Axis. | Hsa_circ_002178 Promotes the Growth and Migration of Breast Cancer Cells and Maintains Cancer Stem-like Cell Properties Through Regulating miR-1258/KDM7A Axis.
Li W, Yang X, Shi C, Zhou Z., Free PMC Article | 06/26/2021 |
| Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells. | Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
Lee KH, Kim BC, Jeong SH, Jeong CW, Ku JH, Kim HH, Kwak C., Free PMC Article | 02/20/2021 |
| JHDM1D-AS1 aggravates the development of gastric cancer through miR-450a-2-3p-PRAF2 axis. | JHDM1D-AS1 aggravates the development of gastric cancer through miR-450a-2-3p-PRAF2 axis.
Wu M, Liu Y, Pu YS, Ma Y, Wang JH, Liu EQ. | 01/16/2021 |
| Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells. | Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells.
Higashijima Y, Matsui Y, Shimamura T, Nakaki R, Nagai N, Tsutsumi S, Abe Y, Link VM, Osaka M, Yoshida M, Watanabe R, Tanaka T, Taguchi A, Miura M, Ruan X, Li G, Inoue T, Nangaku M, Kimura H, Furukawa T, Aburatani H, Wada Y, Ruan Y, Glass CK, Kanki Y., Free PMC Article | 12/12/2020 |
| Histone demethylase KDM7A is required for stem cell maintenance and apoptosis inhibition in breast cancer. | Histone demethylase KDM7A is required for stem cell maintenance and apoptosis inhibition in breast cancer.
Meng Z, Liu Y, Wang J, Fan H, Fang H, Li S, Yuan L, Liu C, Peng Y, Zhao W, Wang L, Li J, Feng J. | 10/24/2020 |
| decreased expression in placenta associated with pre-eclampsia through down-regulating HLA-G | Decreased expression of JHDMID in placenta is associated with preeclampsia through HLA-G.
Luo S, Pei J, Li X, Gu W. | 10/26/2019 |
| KDM7A is potentially a good therapeutic target for prostate cancer drugs. | Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer.
Lee KH, Hong S, Kang M, Jeong CW, Ku JH, Kim HH, Kwak C. | 02/23/2019 |
| KDM7A mediates TNF-alpha-induced ICAM1 protein upregulation. | KDM7A histone demethylase mediates TNF-α-induced ICAM1 protein upregulation by modulating lysosomal activity.
Choi JY, Jo SA. | 06/3/2017 |
| G9a promotes H3K27 methylation of the E-cadherin promoter by upregulating PCL3 to increase PRC2 promoter recruitment and by downregulating the H3K27 demethylase KDM7A to silence E-cadherin gene | G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation.
Pan MR, Hsu MC, Chen LT, Hung WC., Free PMC Article | 12/17/2016 |
| Histone modifier genes (JMJD1C, RREB1, MINA, KDM7A) alter conotruncal heart phenotypes in 22q11.2 deletion syndrome. | Histone Modifier Genes Alter Conotruncal Heart Phenotypes in 22q11.2 Deletion Syndrome.
Guo T, Chung JH, Wang T, McDonald-McGinn DM, Kates WR, Hawuła W, Coleman K, Zackai E, Emanuel BS, Morrow BE., Free PMC Article | 03/26/2016 |
| increased JHDM1D expression suppresses tumor growth by down-regulating angiogenesis under nutrient starvation | Increased expression of histone demethylase JHDM1D under nutrient starvation suppresses tumor growth via down-regulating angiogenesis.
Osawa T, Muramatsu M, Wang F, Tsuchida R, Kodama T, Minami T, Shibuya M., Free PMC Article | 03/10/2012 |
| KIAA1718 is a dual-specificity histone demethylase that regulates neural differentiation through FGF4. | Dual-specificity histone demethylase KIAA1718 (KDM7A) regulates neural differentiation through FGF4.
Huang C, Xiang Y, Wang Y, Li X, Xu L, Zhu Z, Zhang T, Zhu Q, Zhang K, Jing N, Chen CD. | 05/3/2010 |